BOLT WILLIAM J 4
4 · ABIOMED INC · Filed May 18, 2018
Insider Transaction Report
Form 4
ABIOMED INCABMD
BOLT WILLIAM J
SVP, QA and Regulatory Affairs
Transactions
- Award
Common Stock, $.01 par
2018-05-16+1,400→ 63,610 total - Award
Stock Option (Right to Buy)
2018-05-16+3,000→ 3,000 totalExercise: $381.97From: 2019-05-16Exp: 2028-05-16→ Common Stock (3,000 underlying)
Holdings
- 2,000
Stock Option (Right to Buy)
Exercise: $66.25From: 2016-05-13Exp: 2025-05-13→ Common Stock (0 underlying) - 3,000
Stock Option (Right to Buy)
Exercise: $134.51From: 2018-05-15Exp: 2027-05-15→ Common Stock (0 underlying) - 3,334
Stock Option (Right to Buy)
Exercise: $99.62From: 2017-05-24Exp: 2026-05-24→ Common Stock (0 underlying)
Footnotes (4)
- [F1]Grant to reporting person of this option to buy the number of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- [F2]These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- [F3]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
- [F4]Consists of restricted stock units granted to the reporting person. One third of the restricted stock units will vest and the underlying shares will be issued to the reporting person on each of May 16, 2019, May 16, 2020 and May 16, 2021, so long as the reporting person continues to be employed by the issuer on the vesting dates.